Biogen Idec to Rearrange Drug Lineup

October 6, 2010
Scientists at Biogen Idec Inc.’s warren of research labs in Kendall Square are working to discover treatments for diseases ranging from lupus to multiple sclerosis. But for the biotechnology company’s 4,800 employees … the most anticipated development project may be a strategic plan their new chief executive is crafting.